ROIV:NASDAQ
Roivant Sciences Ltd
$35.72
arrow_upward
+0.62%(+0.22) 1D
$35.72
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$35.61
High
$36.00
Low
$35.19
Mkt. cap
25.80B
Avg. vol.
8.96M
Volume
4.37M
52-wk high
$42.50
52-wk low
$15.25
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
Open
$35.61
High
$36.00
Low
$35.19
Mkt. cap
25.80B
Avg. vol.
8.96M
Volume
4.37M
52-wk high
$42.50
52-wk low
$15.25
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
News stories
From web sources and news partners
Stock Traders Daily
·
16 hours ago
How (ROIV) Movements Inform Risk Allocation Models
Investing.com Nigeria
·
1 day ago
Form 4 Roivant Sciences Ltd. For: 2 October By Investing.com
Yahoo Finance
·
3 days ago
Roivant Sciences Ltd. (ROIV) Stock Forecasts
Oligarch Watch
·
1 month ago
How Vivek Ramaswamy’s mom manipulated Alzheimer’s data and made her son rich
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd